This company profile provides a preliminary investigation and analysis of Novartis International AG, a multinational pharmaceutical company based in Basel, Switzerland. Novartis is one of ten companies the Investment Board will consider for further in-depth research for a multimillion-dollar investment. Novartis was created in 1996 from the merger of two Swiss-based chemical/life sciences giants;
01/14/04 op yo TRANSFORMING HUMAN RESOURCES AT NOVARTIS: THE HUMAN RESOURCES INFORMATION SYSTEM (HRIS) Since the early days of the merger, we knew we would need a significant effort to transfer the new company into a high-performance organization.1 —Daniel Vasella, MD, Chairman and CEO, Novartis AG INTRODUCTION tC Since the merger of Ciba-Geigy and Sandoz that created the Swiss healthcare and pharmaceutical company of Novartis in December 1996, CEO Dan Vasella had begun the transformation
Part I: Introduction of Novartis India ______________________________________________ Introduction of the Company: Name of the company: Novartis India Ltd. Industry: Pharmaceuticals Founded: 1996 (from merger) Headquarters: Basel, Switzerland Revenue (2015): 957.35 Crores Registered Office: Address Sandoz House, Shivsagar Estate,, Dr Annie Besant Road, District Mumbai State Maharashtra Pin Code 400018 Tel. No. 022-24958400,022-24958888 Fax No. 24950221 Email : girish.tekchandani@novartis.com
Table of Contents Ch. No. Chapter Name Page no. 1 Introduction of Novartis India 4 2 Production Department 10 3 HR Department 18 4 Finance Department 34 5 Purchase Department 48 6 Marketing Department 53 7 Industrial Analysis 56 8 Mini Project 67 9 Background of the study 68 10 Objectives of the study 70 11 Significance of the Study 71 12 Scope of the Study 72 13 Definitions of Significant Terms Used in the Study 73 14 Literature Review 75 15 Research methodology • Research Design • Population
manufacturing: two case studies on implementation The Authors Amrik S. Sohal, Department of Management, Monash University, Australia Walter W.C. Chung, Department of Manufacturing Engineering, Hong Kong Polytechnic University, Hong Kong Acknowledgements The authors are grateful to the Financial Controller at MelCo and to Mr Richard Siu, now Deputy General Manager of Ciba Specialty Chemicals (China) Ltd. They are also thankful to the Hong Kong Government Industry Department and The Hong Kong Polytechnic
Cairo University Faculty of commerce Business Administration Department “The Impact of Merging and Acquisition Upon profitability “ By: Tahany AbdElzaher Mohamed Under supervision Dr: AhmedFahamyGalal Table of Content Pages Content 1.General Back ground 1. History of Mergers & Acquisitions wave 2.The Past merger and acquisition in pharmaceutical company 3.Definition of